Sleep Disorders Treatment: Global Market Outlook
Report Scope:
In this report, the market has been segmented based on product type, medication type, and geography. The report provides an overview of the global sleep disorders treatment market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. The scope of the report includes pharmaceutical sales and anxiolytic consumption, as well as hypnotics and sedative consumption, non-mental health related disorders, and all other types of medications that aid in improving sleep quality.
The report covers the market for sleep disorders treatment across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for Sleep Disorder Treatments in 2021 and provides projections for the expected market size through 2027.
Different types of drugs are used to treat insomnia, sleep apnea, and other sleep disorder problems. Additionally, the report discusses the different medication types used to treat sleep disorders. This report does not include any therapeutic devices used for treating patients. Medications generally help induce sleep by inhibiting central nervous system activity. Sleeping tablets are routinely used to treat insomnia. The impact of sleep drugs depends on their chemical composition. The growing product approval for sleep drugs is another reason for conducting this market study.
Report Includes:
In this report, the market has been segmented based on product type, medication type, and geography. The report provides an overview of the global sleep disorders treatment market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. The scope of the report includes pharmaceutical sales and anxiolytic consumption, as well as hypnotics and sedative consumption, non-mental health related disorders, and all other types of medications that aid in improving sleep quality.
The report covers the market for sleep disorders treatment across different regions. It also highlights major trends and challenges that affect the market and the vendor landscape. The report estimates the global market for Sleep Disorder Treatments in 2021 and provides projections for the expected market size through 2027.
Different types of drugs are used to treat insomnia, sleep apnea, and other sleep disorder problems. Additionally, the report discusses the different medication types used to treat sleep disorders. This report does not include any therapeutic devices used for treating patients. Medications generally help induce sleep by inhibiting central nervous system activity. Sleeping tablets are routinely used to treat insomnia. The impact of sleep drugs depends on their chemical composition. The growing product approval for sleep drugs is another reason for conducting this market study.
Report Includes:
- 14 data tables and 14 additional tables
- An updated overview and in-depth analysis of the global market for global sleep disorder treatment
- Analyses of the global market trends, with historic market revenue data for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of industry growth driving factors and major technology issues and challenges affecting the market for sleep disorders treatment as a basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global sleep disorder treatment market in USD million values, and corresponding market share analysis by product type, drug type, and region
- A comparative study and Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the sleep disorder treatment market
- Holistic review of the impact of the COVID-19 pandemic and the Russia-Ukraine war on the global sleep disorders treatment markets
- Coverage of the technological, economic, and business considerations of the global sleep disorder treatment market, with market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, and segmental revenues
- Company profiles of major players within the industry, including Jazz Pharmaceuticals plc, Pfizer Inc., Sanofi S.A., and Zydus Cadila Group
CHAPTER 1 MARKET OUTLOOK
1.1 Market Snapshot
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1 Overview
3.2 Different Types of Sleep Disorders
3.2.1 Insomnia
3.2.2 Sleep Apnea
3.2.3 Snoring
3.2.4 Sleep Paralysis
3.2.5 Sleep Talking
3.2.6 Narcolepsy
3.2.7 Treatment for Sleep Disorders
3.3 Future of Sleep Disorder Treatment
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Macroeconomic Factors of Market for Sleep Disorder Treatments
3.5.1 Impact of COVID-19 on Market for Sleep Disorder Treatments
3.5.2 Impact of Russia-Ukraine War on Market for Sleep Disorder Treatments
CHAPTER 4 MARKET OPPORTUNITIES AND TECHNOLOGY SNAPSHOT
4.1 Market Opportunities
4.1.1 Implementation of Artificial Intelligence in Sleep Disorders
4.1.2 Growing Demand for Home Sleep Test
4.2 Regulation of Sleep
4.2.1 Neurotransmitter Regulation
4.2.2 Hypothalamic Regulation
4.2.3 Pharmaceutical Regulation
4.3 Various Distribution Channels
4.3.1 Online Pharmacy
4.3.2 Offline Pharmacy
4.4 Type of Product
4.4.1 Branded
4.4.2 Generic
CHAPTER 5 MARKET BREAKDOWN BY DRUG/PRODUCT TYPE
5.1 Market for Sleep Disorder Treatments by Type of Drug
5.1.1 Benzodiazepines
5.1.2 Nonbenzodiazepines
5.1.3 Antidepressants
5.1.4 Melatonin Antagonists
5.1.5 Others
5.2 Market for Sleep Disorder Treatments by Type of Product
5.2.1 Over-the-Counter (OTC) Drugs
5.2.2 Prescription-Based Drugs
5.2.3 Herbal-Based Drugs
CHAPTER 6 MARKET BREAKDOWN BY REGION
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
CHAPTER 7 COMPANY PROFILES
AZURITY PHARMACEUTICALS INC.
HIKMA PHARMACEUTICALS PLC
IDORSIA PHARMACEUTICALS LTD.
JAZZ PHARMACEUTICALS PLC
MERCK & CO. INC.
PFIZER INC.
SANOFI S.A.
VANDA PHARMACEUTICALS
VIATRIS INC.
ZYDUS CADILA GROUP
CHAPTER 8 PROJECT SCOPE AND METHODOLOGY
8.1 Scope of Report
8.2 Methodology
8.3 Analyst's Credentials
8.4 BCC Custom Research
8.5 Related BCC Research Reports
1.1 Market Snapshot
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1 Overview
3.2 Different Types of Sleep Disorders
3.2.1 Insomnia
3.2.2 Sleep Apnea
3.2.3 Snoring
3.2.4 Sleep Paralysis
3.2.5 Sleep Talking
3.2.6 Narcolepsy
3.2.7 Treatment for Sleep Disorders
3.3 Future of Sleep Disorder Treatment
3.4 Market Dynamics
3.4.1 Market Drivers
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Macroeconomic Factors of Market for Sleep Disorder Treatments
3.5.1 Impact of COVID-19 on Market for Sleep Disorder Treatments
3.5.2 Impact of Russia-Ukraine War on Market for Sleep Disorder Treatments
CHAPTER 4 MARKET OPPORTUNITIES AND TECHNOLOGY SNAPSHOT
4.1 Market Opportunities
4.1.1 Implementation of Artificial Intelligence in Sleep Disorders
4.1.2 Growing Demand for Home Sleep Test
4.2 Regulation of Sleep
4.2.1 Neurotransmitter Regulation
4.2.2 Hypothalamic Regulation
4.2.3 Pharmaceutical Regulation
4.3 Various Distribution Channels
4.3.1 Online Pharmacy
4.3.2 Offline Pharmacy
4.4 Type of Product
4.4.1 Branded
4.4.2 Generic
CHAPTER 5 MARKET BREAKDOWN BY DRUG/PRODUCT TYPE
5.1 Market for Sleep Disorder Treatments by Type of Drug
5.1.1 Benzodiazepines
5.1.2 Nonbenzodiazepines
5.1.3 Antidepressants
5.1.4 Melatonin Antagonists
5.1.5 Others
5.2 Market for Sleep Disorder Treatments by Type of Product
5.2.1 Over-the-Counter (OTC) Drugs
5.2.2 Prescription-Based Drugs
5.2.3 Herbal-Based Drugs
CHAPTER 6 MARKET BREAKDOWN BY REGION
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
CHAPTER 7 COMPANY PROFILES
AZURITY PHARMACEUTICALS INC.
HIKMA PHARMACEUTICALS PLC
IDORSIA PHARMACEUTICALS LTD.
JAZZ PHARMACEUTICALS PLC
MERCK & CO. INC.
PFIZER INC.
SANOFI S.A.
VANDA PHARMACEUTICALS
VIATRIS INC.
ZYDUS CADILA GROUP
CHAPTER 8 PROJECT SCOPE AND METHODOLOGY
8.1 Scope of Report
8.2 Methodology
8.3 Analyst's Credentials
8.4 BCC Custom Research
8.5 Related BCC Research Reports
LIST OF TABLES
Summary Table: Global Market for Sleep Disorder Treatments, by Region, Through 2027
Table 1: Examples of Different Drugs
Table 2: Examples of Different Drugs
Table 3: Global Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 4: Global Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 5: Global Market for Sleep Disorder Treatments, by Region, Through 2027
Table 6: North American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 7: North American Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 8: European Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 9: European Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 10: Asia-Pacific Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 11: Asia-Pacific Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 12: Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 13: Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 14: Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 15: Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 16: Azurity Pharmaceuticals Inc.: Product Offering
Table 17: Hikma Pharmaceuticals plc: Product Offering
Table 18: Idorsia Pharmaceuticals Ltd.: Product Offering
Table 19: Jazz Pharmaceuticals plc: Product Offering
Table 20: Jazz Pharmaceuticals plc: Recent Developments, 2022
Table 21: Merck & Co. Inc.: Product Offering
Table 22: Pfizer Inc.: Product Offering
Table 23: Sanofi S.A.: Product Offering
Table 24: Vanda Pharmaceuticals: Product Offering
Table 25: Viatris Inc.: Product Offering
Table 26: Zydus Cadila Group: Product Offering
Table 27: Zydus Cadila Group: Recent Developments, 2022
Summary Table: Global Market for Sleep Disorder Treatments, by Region, Through 2027
Table 1: Examples of Different Drugs
Table 2: Examples of Different Drugs
Table 3: Global Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 4: Global Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 5: Global Market for Sleep Disorder Treatments, by Region, Through 2027
Table 6: North American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 7: North American Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 8: European Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 9: European Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 10: Asia-Pacific Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 11: Asia-Pacific Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 12: Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 13: Latin American Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 14: Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Drug, Through 2027
Table 15: Middle Eastern and African Market for Sleep Disorder Treatments, by Type of Product, Through 2027
Table 16: Azurity Pharmaceuticals Inc.: Product Offering
Table 17: Hikma Pharmaceuticals plc: Product Offering
Table 18: Idorsia Pharmaceuticals Ltd.: Product Offering
Table 19: Jazz Pharmaceuticals plc: Product Offering
Table 20: Jazz Pharmaceuticals plc: Recent Developments, 2022
Table 21: Merck & Co. Inc.: Product Offering
Table 22: Pfizer Inc.: Product Offering
Table 23: Sanofi S.A.: Product Offering
Table 24: Vanda Pharmaceuticals: Product Offering
Table 25: Viatris Inc.: Product Offering
Table 26: Zydus Cadila Group: Product Offering
Table 27: Zydus Cadila Group: Recent Developments, 2022
LIST OF FIGURES
Summary Figure: Global Market Shares of Sleep Disorder Treatments, by Region, 2021
Figure 1: Different Types of Sleep Disorders
Figure 2: Different Types of Treatment for Sleep Disorders
Figure 3: Global Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 4: Global Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 5: Global Market Shares of Sleep Disorder Treatments, by Region, 2021
Figure 6: Rate of Insomnia in Regions of the the U.S., 2022
Figure 7: North American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 8: North American Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 9: Prevalence of Anxiety, Depression, and Stress in Selected European Countries, 2022
Figure 10: European Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 11: European Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 12: Top 10 Countries with Highest Number of Citizens Aged Above 65, Asia-Pacific, 2022
Figure 13: Number of People with Diabetes, Asia-Pacific, by Country, 2022
Figure 14: Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 15: Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 16: Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 17: Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 18: Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 19: Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Summary Figure: Global Market Shares of Sleep Disorder Treatments, by Region, 2021
Figure 1: Different Types of Sleep Disorders
Figure 2: Different Types of Treatment for Sleep Disorders
Figure 3: Global Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 4: Global Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 5: Global Market Shares of Sleep Disorder Treatments, by Region, 2021
Figure 6: Rate of Insomnia in Regions of the the U.S., 2022
Figure 7: North American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 8: North American Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 9: Prevalence of Anxiety, Depression, and Stress in Selected European Countries, 2022
Figure 10: European Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 11: European Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 12: Top 10 Countries with Highest Number of Citizens Aged Above 65, Asia-Pacific, 2022
Figure 13: Number of People with Diabetes, Asia-Pacific, by Country, 2022
Figure 14: Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 15: Asia-Pacific Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
Figure 16: Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 17: Latin American Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 18: Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Drug, 2021
Figure 19: Middle Eastern and African Market Shares of Sleep Disorder Treatments, by Type of Product, 2021
